| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $478M | $460M | — | 3.9% | — |
| Op. Income | $118M | $97M | — | 22.5% | — |
| Gross Margin | 55.1% | 53.1% | — | 1.9pp | — |
| Net Margin | 5.7% | 11.3% | — | -5.6pp | — |
| EPS (Diluted) | $0.17 | $0.29 | — | -41.4% | — |
| Free Cash Flow | $213M | $51M | — | 317.8% | — |
| Item | Amount |
|---|---|
| REVENUE | $478M |
| Cost of Revenue | $215M |
| GROSS PROFIT | $263M |
| R&D Expenses | $4M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $141M |
| Other Expenses | $0 |
| Operating Expenses | $144M |
| Cost & Expenses | $359M |
| OPERATING INCOME | $118M |
| Interest Income | $0 |
| Interest Expense | $26M |
| Other Income/Expenses | -$80M |
| INCOME BEFORE TAX | $38M |
| Income Tax Expense | $11M |
| Net Income from Continuing Ops | $27M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $27M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $27M |
| D&A | $27M |
| EBIT | $65M |
| EBITDA | $92M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $478M |
| Cost of Revenue | $215M |
| GROSS PROFIT | $263M |
| R&D Expenses | $4M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $141M |
| Other Expenses | $0 |
| Operating Expenses | $144M |
| Cost & Expenses | $359M |
| OPERATING INCOME | $118M |
| Interest Income | $0 |
| Interest Expense | $26M |
| Other Income/Expenses | -$80M |
| INCOME BEFORE TAX | $38M |
| Income Tax Expense | $11M |
| Net Income from Continuing Ops | $27M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $27M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $27M |
| D&A | $27M |
| EBIT | $65M |
| EBITDA | $92M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $27M |
| Depreciation & Amortization | $27M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $38M |
| Other Non-Cash Items | $37M |
| Change in Working Capital | $104M |
| OPERATING CASH FLOW | $234M |
| Capital Expenditure | -$20M |
| Acquisitions (Net) | -$2M |
| Purchases of Investments | -$66M |
| Sales/Maturities of Investments | $5M |
| Other Investing Activities | $69M |
| NET CASH FROM INVESTING | -$15M |
| Net Debt Issuance | -$89M |
| Common Stock Repurchased | -$127M |
| Common Dividends Paid | -$14M |
| Other Financing Activities | -$25M |
| NET CASH FROM FINANCING | -$255M |
| FREE CASH FLOW | $213M |
| Net Change in Cash | -$36M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $285M |
| Short-Term Investments | $12M |
| Net Receivables | $668M |
| Inventory | $66M |
| Other Current Assets | $69M |
| TOTAL CURRENT ASSETS | $1.1B |
| PP&E (Net) | $317M |
| Goodwill | $747M |
| Intangible Assets | $15M |
| Long-Term Investments | $605M |
| Tax Assets | $0 |
| Other Non-Current Assets | $385M |
| TOTAL NON-CURRENT ASSETS | $2.1B |
| TOTAL ASSETS | $3.2B |
| Account Payables | $845M |
| Short-Term Debt | $46M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $652M |
| TOTAL CURRENT LIABILITIES | $1.5B |
| Long-Term Debt | $2.1B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $73M |
| Other Non-Current Liabilities | $175M |
| TOTAL NON-CURRENT LIABILITIES | $2.4B |
| TOTAL LIABILITIES | $4.0B |
| Common Stock | $270M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $2.7B |
| Treasury Stock | -$2.9B |
| Accum. Other Comp. Income | -$789M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$802M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$802M |
| TOTAL LIABILITIES & EQUITY | $3.2B |
| Total Debt | $2.2B |
| Net Debt | $1.9B |
